📰 Abt News
Page 193 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
March 26, 2023
DeDora Capital Inc. lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 13,513 shares of the healthcare product maker’s stock after selling 132 shares during the period. DeDora Capital Inc.’s holdings in Abbott Laboratories […]
March 26, 2023
Kovitz Investment Group Partners LLC lessened its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 4.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 96,859 shares of the healthcare product maker’s stock after selling 4,130 shares during the quarter. Kovitz Investment Group Partners LLC’s holdings in […]
March 26, 2023
Home Federal Bank of Tennessee cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 0.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,385 shares of the healthcare product maker’s stock after selling 180 shares during the […]
March 26, 2023
Sweet Financial Partners LLC raised its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 33.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,810 shares of the healthcare product maker’s stock after acquiring an additional 3,189 shares during the […]
March 26, 2023
Arcblock (ABT) traded up 0.7% against the dollar during the one day period ending at 18:00 PM E.T. on March 26th. One Arcblock token can now be purchased for $0.12 or 0.00000442 BTC on exchanges. During the last week, Arcblock has traded 11.1% lower against the dollar. Arcblock has a market cap of $12.20 million […]
March 25, 2023
Mckinley Capital Management LLC Delaware trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 50.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 60,244 shares of the healthcare product maker’s stock after selling 61,757 shares […]
March 25, 2023
Cerro Pacific Wealth Advisors LLC grew its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 16.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,162 shares of the healthcare product maker’s stock after buying an additional 1,904 shares during the […]
March 25, 2023
Prentice Wealth Management LLC increased its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 8.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,650 shares of the healthcare product maker’s stock after purchasing an additional 269 shares during the period. Prentice Wealth Management LLC’s […]
March 25, 2023
Resource Consulting Group Inc. reduced its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 25.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,764 shares of the healthcare product maker’s stock after selling 930 shares during the period. Abbott Laboratories makes up […]
March 25, 2023
Ritholtz Wealth Management grew its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 83.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 57,743 shares of the healthcare product maker’s stock after acquiring an additional 26,246 shares during the quarter. Ritholtz Wealth Management’s […]